(Q46568744)

English

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

hyperparathyroidism

1 reference

based on heuristic

inferred from title

author name string

Yuko Oyama

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Junichiro James Kazama

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Kentaro Omori

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Noboru Higuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Shigemi Kameda

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Suguru Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Yumi Ito

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Hiroki Maruyama

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Ichiei Narita

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Fumitake Gejyo

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Clinical and experimental nephrology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

142-147

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

https://scigraph.springernature.com/pub.10.1007/s10157-005-0342-2

0 references

Treatment of secondary hyperparathyroidism with vitamin D derivatives and calcimimetics before and after start of dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS10157-005-0342-2

21 January 2018

Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical and surgical aspects of parathyroidectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of phosphorus in the pathogenesis of secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are we mismanaging calcium and phosphate metabolism in renal failure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Secondary Hyperparathyroidism: The Importance and the Challenge of Controlling Parathyroid Hormone Levels without Elevating Calcium, Phosphorus, and Calcium-Phosphorus Product

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of refractory secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 22-oxacalcitriol on Secondary Hyperparathyroidism in Hemodialysis Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receiver operating characteristic (ROC) methodology: the state of the art.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15980949

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-005-0342-2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15980949

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46568744&oldid=2118547841"